Brind.

The IVD market in India is driven by NCDs, with key companies like Roche, Sysmex, Danaher, Qiagen, and Quidel leading innovation-driven growth.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Danaher Corporation Quidel Hoffmann-La Roche Qiagen Sysmex Corporation

Keep exploring

The entities involved

Danaher Corporation
American conglomerate
- Sidharth Kapileshwar joins MaxCyte as Chief Corporate Development Officer after leaving Danaher Corporation.Wed 14:03
Quidel
company

Nothing else this week.
Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08
Qiagen
company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Jul 21GlobeNewswireIndia In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, D